Earth Science Tech, Inc. (ETST) Plans to Battle Opioid Addiction with Human Clinical Trials in 2019
Centers for Disease Control and Prevention, in March 2018, estimated ‘economic burden’ of opioid misuse at $78.5 billion annually ETST plans to complete white paper, begin human clinical trials by 2019; company intends to investigate drugs that combine mineral element and cannabinoid industrial hemp oil Goal for biotech company is to fight opioid addiction with over-the-counter (OTC) treatment drug and a cannabinoid companion generic drug Earth Science Tech, Inc. (OTC: ETST) is planning to fight opioid addiction in the near future by completing its white paper and beginning human clinical trials in 2019. The epidemic is projected to claim nearly…